Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseases

6 Mar 2023

Abstract excerpt

Ocular diseases are a highly heterogeneous group of phenotypes, caused by a spectrum of genetic variants and environmental factors that exhibit diverse clinical symptoms. As a result of its anatomical location, structure and immune privilege, the eye is an ideal system to assess and validate novel genetic therapies. Advances in genome editing have revolutionized the field of biomedical science, enabling...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Cytomegalovirus and herpesvirus research
Share to Retinal Development and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36877952
DOI: 10.1111/febs.16771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseasesPMID 36877952Read ↗

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Semantic proximity Read ↗

The application and progression of CRISPR/Cas9 technology in ophthalmological diseasesSemantic proximity Read ↗

Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseasesSemantic proximity Read ↗

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseasesSemantic proximity Read ↗

CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.Semantic proximity Read ↗

CRISPR Interference-Potential Application in Retinal Disease.Semantic proximity Read ↗

Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnologySemantic proximity Read ↗

Precision genome editing in the eye.Semantic proximity Read ↗

CRISPR Technology for Ocular AngiogenesisSemantic proximity Read ↗

In Vivo Applications of CRISPR-Based Genome Editing in the RetinaSemantic proximity Read ↗

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicineSemantic proximity Read ↗

CRISPR-Cas9 Gene Therapy Effects on Inherited Eye DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.